Placental protein 13 as an early predictor in egyptian patients with preeclampsia, correlation to risk, and association with outcome

Journal of Investigative Medicine

Volumn 60, Issue 5, 2012, Pages 818-822

  El Sherbiny, Walid S ^a   Soliman, Ahmed ^a   Nasr, Aml S ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Enzyme linked immunosorbent assay; MRNA; PP13; Preeclampsia; RT PCR

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; PLACENTA PROTEIN; PLACENTA PROTEIN 13; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; OUTCOME ASSESSMENT; PREECLAMPSIA; PRENATAL DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; EGYPT; FEMALE; GALECTINS; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; PROSPECTIVE STUDIES; RISK FACTORS; RNA, MESSENGER; YOUNG ADULT;

EID: 84860805991     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31824e9a68     Document Type: Conference Paper

References (19)

1. Drife JO, Magowan (eds). Clinical Obstetrics and Gynaecology, chapter 39, pp 367-370.
2. Kumar V, Abbas AK, Fausto N, et al. Robbins and Cotran Pathological Basis of Disease. 7th ed. Philadelphia, PA: Saunders, 2004.
3. Maynard S, Min J, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-658. (Pubitemid 36278583)
4. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642-649. (Pubitemid 43865232)
5. Bohn H, Krause W, Winckler W. Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17). Oncodev Biol Med. 1983;4(5):343-350. (Pubitemid 13078219)
6. Than NG, Sumegi B, Than GN, et al. Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP-13), a new lysophospholipase, homologue of human eosinophil Charcote Leyden crystal protein. Placenta. 1999;20(8):703-710. (Pubitemid 29479016)
7. Visegrady B, Than NG, Kiler F, et al. Homology modeling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng. 2001;14(11):875-880. (Pubitemid 34024179)
8. Burger O, Pick E, Zwickel J, et al. Placental protein 13 (PP-13): Effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta. 2004;25(7):608-622. (Pubitemid 38950314)
9. Than NG, Pick E, Bellyei S, et al. Functional analyses of placental protein 13/galectin-13. Eur J Biochem. 2004;271(6):1065-1078. (Pubitemid 38373040)
10. Nicolaides KH, Bindra R, Turan OM, et al. A novel approach to first trimester screening for early pre-eclampsia combining serum PP13 and Doppler ultrasound. Ultrasound Obstet Gynecol. 2006;27(1):13-17. (Pubitemid 43129084)
11. Spencer K, Cowans NJ, Chafetz I, et al. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;29(2):128-134. (Pubitemid 46326583)
12. Chafetz I, Kuhnreich I, Sammar M, et al. First trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2007;197(1):35.e1-e7.
13. Sammar M, Nisemblat S, Fleischfarb Z, et al. Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery. Placenta. 2011;32(suppl):S30-S36.
14. Than NG, Bohn H, Toth P, et al. From basic research to clinical application of placental proteinsVa workshop report. Placenta. 2004;25(suppl A):S109-S111. (Pubitemid 38514967)
15. Huppertz B, Sammar M, Chefetz I, et al. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther. 2008;24(3):230-236.
16. Than NG, Abdul Rahman O, Magenheim R, et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch. 2008;453(4):387-400.
17. Wortelboer EJ, Koster MP, Cuckle HS, et al. First-trimester placental protein 13 and placental growth factor: Markers for identification of women destined to develop early-onset pre-eclampsia. BJOG. 2010;117(11):1384-1389.
18. Gonen R, Shahar R, Grimpel YI, et al. Placental protein 13 as an early marker for pre-eclampsia: A prospective longitudinal study. BJOG. 2008;115(12):1465-1472.
19. Shimizu H, Sekizawa A, Purwosunu Y, et al. PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. Prenat Diagn. 2009;29(13):1231-1236.